Urology Clinical Learning Center
Perspectives on NMIBC diagnosis, risk assessment, and coordinated care.
Biomarkers
Urinary biomarkers have long been investigated as a less invasive way to support bladder cancer detection and surveillance, but translating promising molecular signals into routine clinical practice remains challenging.
Read article →
Surveillance
Surveillance is a cornerstone of non-muscle-invasive bladder cancer (NMIBC) management, but real-world follow-up may not consistently reflect a patient's risk of recurrence and progression.
Read article →
Patient outcomes
For patients with non-muscle-invasive bladder cancer (NMIBC), the burden of disease extends beyond traditional measures of recurrence and progression.
Read article →
Prevention
Smoking remains one of the most important preventable risk factors for bladder cancer, and new global data illustrate how substantial its impact continues to be.
Read article →
Pathology
Not all bladder cancers follow the same clinical course.
Read article →
Research
Cystoscopy remains central to bladder cancer diagnosis and surveillance, but the need for repeated invasive procedures has driven an expanding search for reliable alternatives and complementary tools.
Read article →
Treatment outcomes
A strong pathological response to neoadjuvant chemotherapy is generally viewed as an encouraging sign in muscle-invasive bladder cancer, but new research suggests that response alone may not fully capture a patient's longer-term outlook.
Read article →
Epidemiology
Bladder cancer is predominantly associated with older adults, but a global analysis suggests that the number of cases occurring before age 50 has increased substantially over the past three decades.
Read article →
Access to care
Timely access to urologists, oncologists, and appropriate treatment is an important part of bladder cancer management, yet a large analysis of U.S. Medicare beneficiaries found measurable racial and ethnic differences across several points in the care pathway.
Read article →
Diagnosis
Microscopic hematuria is common, but only a small proportion of patients undergoing evaluation will ultimately be diagnosed with bladder cancer.
Read article →